Assay of human stem cells by repopulation of NOD/SCID mice
- PMID: 9368342
- DOI: 10.1002/stem.5530150826
Assay of human stem cells by repopulation of NOD/SCID mice
Abstract
The only conclusive method to assay stem cells is to follow their ability to repopulate conditioned recipients, making it difficult to study human stem cells. The development of systems to transplant human hematopoietic cells into immune-deficient mice lays the foundation for such an experimental repopulation assay for primitive human cells. Cell purification and gene marking studies have shown that the repopulating cells, termed severe-combined immunodeficiency (SCID) mouse-repopulating cells (SRC), are primitive and distinct from most of the progenitors that are detected using short and long-term in vitro culture assays. The SRC are exclusively CD34+CD38- and poorly infected with retrovirus vectors. These gene marking data are reminiscent of the human clinical trials establishing that the SRC assay is a good surrogate to develop improved transduction methods. Limiting dilution analysis has been used to establish a quantitative assay for SRC that can be used to precisely determine the effect of various cytokine cocktails on the proliferation and differentiation of SRC during in vitro culture.
Similar articles
-
Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.Stem Cells. 1999;17(3):152-61. doi: 10.1002/stem.170152. Stem Cells. 1999. PMID: 10342558
-
Intra-bone marrow transplantation facilitates pauci-clonal human hematopoietic repopulation of NOD/SCID/beta2m(-/-) mice.Exp Hematol. 2005 Nov;33(11):1417-26. doi: 10.1016/j.exphem.2005.07.007. Exp Hematol. 2005. PMID: 16263425
-
Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.Bone Marrow Transplant. 1999 Feb;23(3):203-9. doi: 10.1038/sj.bmt.1701564. Bone Marrow Transplant. 1999. PMID: 10084250
-
Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays.Oncogene. 2004 Sep 20;23(43):7210-22. doi: 10.1038/sj.onc.1207941. Oncogene. 2004. PMID: 15378081 Review.
-
SCID mouse models of human stem cell engraftment.Stem Cells. 1998;16(3):166-77. doi: 10.1002/stem.160166. Stem Cells. 1998. PMID: 9617892 Review.
Cited by
-
Normal Hematopoetic Stem and Progenitor Cells Can Exhibit Metabolic Flexibility Similar to Cancer Cells.Front Oncol. 2020 May 12;10:713. doi: 10.3389/fonc.2020.00713. eCollection 2020. Front Oncol. 2020. PMID: 32528878 Free PMC article.
-
Comparative immunity of antigen recognition, differentiation, and other functional molecules: similarities and differences among common marmosets, humans, and mice.Exp Anim. 2018 Jul 30;67(3):301-312. doi: 10.1538/expanim.17-0150. Epub 2018 Mar 8. Exp Anim. 2018. PMID: 29415910 Free PMC article. Review.
-
Pleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function.Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):3-9. doi: 10.1016/j.prostaglandins.2011.06.004. Epub 2011 Jun 21. Prostaglandins Other Lipid Mediat. 2011. PMID: 21722751 Free PMC article. Review.
-
Cancer stem cells and epithelial ovarian cancer.J Oncol. 2010;2010:105269. doi: 10.1155/2010/105269. Epub 2011 Jan 24. J Oncol. 2010. PMID: 21318146 Free PMC article.
-
Genetic and functional diversity of propagating cells in glioblastoma.Stem Cell Reports. 2015 Jan 13;4(1):7-15. doi: 10.1016/j.stemcr.2014.11.003. Epub 2014 Dec 18. Stem Cell Reports. 2015. PMID: 25533637 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous